HomeCompareRVTTY vs MRK

RVTTY vs MRK: Dividend Comparison 2026

RVTTY yields 0.80% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.0K in total portfolio value
10 years
RVTTY
RVTTY
● Live price
0.80%
Share price
$10.23
Annual div
$0.08
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$84.48
Full RVTTY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RVTTY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRVTTYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RVTTY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RVTTY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RVTTY
Annual income on $10K today (after 15% tax)
$68.16/yr
After 10yr DRIP, annual income (after tax)
$71.81/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,256.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RVTTY + MRK for your $10,000?

RVTTY: 50%MRK: 50%
100% MRK50/50100% RVTTY
Portfolio after 10yr
$38.8K
Annual income
$4,941.31/yr
Blended yield
12.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RVTTY
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RVTTY buys
0
MRK buys
0
No recent congressional trades found for RVTTY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRVTTYMRK
Forward yield0.80%2.76%
Annual dividend / share$0.08$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20.8K$56.8K
Annual income after 10y$84.48$9,798.13
Total dividends collected$825.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RVTTY vs MRK ($10,000, DRIP)

YearRVTTY PortfolioRVTTY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,780$80.19$11,206$366.19$426.00MRK
2$11,616$80.79$12,650$502.35$1.0KMRK
3$12,510$81.36$14,407$694.19$1.9KMRK
4$13,468$81.89$16,585$967.82$3.1KMRK
5$14,493$82.39$19,342$1,363.89$4.8KMRK
6$15,590$82.86$22,913$1,947.19$7.3KMRK
7$16,765$83.31$27,662$2,823.89$10.9KMRK
8$18,022$83.72$34,159$4,173.35$16.1KMRK
9$19,368$84.11$43,337$6,308.80$24.0KMRK
10$20,808$84.48$56,776$9,798.13$36.0KMRK

RVTTY vs MRK: Complete Analysis 2026

RVTTYStock

Rovio Entertainment Oyj, a games-first entertainment company, creates, develops, and publishes mobile games in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Games, Brand Licensing, and Other segments. The company offers various mobile games through mobile application stores; produces movies; and licenses various consumer and entertainment products. It also provides physical merchandise, including toys and apparel, as well as location-based entertainment, such as activity parks; and books and comics, animated series, and digital products. Rovio Entertainment Oyj was incorporated in 2003 and is headquartered in Espoo, Finland.

Full RVTTY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RVTTY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RVTTY vs SCHDRVTTY vs JEPIRVTTY vs ORVTTY vs KORVTTY vs MAINRVTTY vs JNJRVTTY vs ABBVRVTTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.